438 related articles for article (PubMed ID: 22364832)
1. Hyperleukocytosis, leukostasis and leukapheresis: practice management.
Ganzel C; Becker J; Mintz PD; Lazarus HM; Rowe JM
Blood Rev; 2012 May; 26(3):117-22. PubMed ID: 22364832
[TBL] [Abstract][Full Text] [Related]
2. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
Korkmaz S
Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
[TBL] [Abstract][Full Text] [Related]
3. How we approach a patient with symptoms of leukostasis requiring emergent leukocytapheresis.
Pham HP; Schwartz J
Transfusion; 2015 Oct; 55(10):2306-11; quiz 2305. PubMed ID: 26267387
[TBL] [Abstract][Full Text] [Related]
4. Hyperleukocytosis and leukostasis: management of a medical emergency.
Giammarco S; Chiusolo P; Piccirillo N; Di Giovanni A; Metafuni E; Laurenti L; Sica S; Pagano L
Expert Rev Hematol; 2017 Feb; 10(2):147-154. PubMed ID: 27967252
[TBL] [Abstract][Full Text] [Related]
5. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
[TBL] [Abstract][Full Text] [Related]
6. Hyperleukocytosis and leukostasis in acute and chronic leukemias.
Macaron W; Sargsyan Z; Short NJ
Leuk Lymphoma; 2022 Aug; 63(8):1780-1791. PubMed ID: 35357988
[TBL] [Abstract][Full Text] [Related]
7. [Leukapheresis in children with chronic myeloid leukemia and pulmonary leukostasis].
Bubała H; Sońta-Jakimczyk D; Janik-Moszant A; Szczepański T; Tomaszewska R; Drybańska B; Sierantowicz-Zdaniewicz U; Frankiewicz E
Pol Merkur Lekarski; 2004 Nov; 17(101):500-2. PubMed ID: 15754643
[TBL] [Abstract][Full Text] [Related]
8. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
[TBL] [Abstract][Full Text] [Related]
9. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis.
Zhao J; Bewersdorf JP; Jaszczur S; Kowalski A; Perreault S; Schiffer M; Gore S; Podoltsev N; Prebet T; Shallis R; Zeidan AM
Leuk Lymphoma; 2021 May; 62(5):1195-1202. PubMed ID: 33325761
[TBL] [Abstract][Full Text] [Related]
10. [Leukostasis and tumor lysis: important complications of hyperleukocytosis].
Schellongowski P; Staudinger T
Internist (Berl); 2013 Sep; 54(9):1051-60. PubMed ID: 23943008
[TBL] [Abstract][Full Text] [Related]
11. Acute leukemia with a very high leukocyte count: confronting a medical emergency.
Majhail NS; Lichtin AE
Cleve Clin J Med; 2004 Aug; 71(8):633-7. PubMed ID: 15449758
[TBL] [Abstract][Full Text] [Related]
12. Leukapheresis treatment in elderly acute leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Erkurt MA; Kuku I; Kaya E; Gozukara Bag H; Nizam I; Koroglu M; Yigit A; Ozgul M
J Clin Apher; 2016 Feb; 31(1):53-8. PubMed ID: 26011305
[TBL] [Abstract][Full Text] [Related]
13. A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis.
Shafique S; Bona R; Kaplan AA
Ther Apher Dial; 2007 Apr; 11(2):146-9. PubMed ID: 17381536
[TBL] [Abstract][Full Text] [Related]
14. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
[TBL] [Abstract][Full Text] [Related]
15. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore.
Tan D; Hwang W; Goh YT
Ann Acad Med Singap; 2005 Apr; 34(3):229-34. PubMed ID: 15902342
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic leukocytapheresis in infants and children with leukemia and hyperleukocytosis: A single institution experience.
Thapa N; Pham R; Cole C; Meinershagen M; Bowman PW; Ray A
J Clin Apher; 2018 Jun; 33(3):316-323. PubMed ID: 29193219
[TBL] [Abstract][Full Text] [Related]
18. The effect of the time from diagnosis to induction therapy on prognosis in patients with acute leukemia undergoing leukapheresis for symptomatic hyperleukocytosis.
Pınar İE; Özkocaman V; Ersal T; Dağtekin ME; Yalçın C; Orhan B; Candar Ö; Çubukçu S; Güllü Koca T; Gürsoy V; Özkalemkaş F
Ther Apher Dial; 2023 Aug; 27(4):802-812. PubMed ID: 37039816
[TBL] [Abstract][Full Text] [Related]
19. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
[No Abstract] [Full Text] [Related]
20. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome.
Blum W; Porcu P
Semin Thromb Hemost; 2007 Jun; 33(4):350-4. PubMed ID: 17525892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
